Plant Products

Medicinal plants are an integral part of traditional medicine since ancient era, until now. Polyphenols are the most explored natural compounds due to their potential health benefits and the identification of new naturally sources rich in polyphenols is one of the main research goals in the development of the pharmaceutical industry. In the process of identifying of pharmaceutical forms and new drugs of plant origin, phytochemical studies are essential, by detecting and dosing the chemical compounds with pharmacotherapeutic potential. Medicinal plants: Agrimonia eupatoria L., Cichorium intybus L., Cynara scolymus L, Hypericum perforatum L., Rubus frucicosus L. are species rich in polyphenols with various pharmacological beneficial effects and can serve as sources of vegetal products for the national pharmaceutical industry.Plantele medicinale fac parte integrantă din medicina tradiţională din epoca antică până în prezent. Polifenolii sunt cei mai exploraţi compuși chimici datorită b...

Aim: Obesity is increasing globally by leaps and bounds and thus the incidence of type 2 diabetes mellitus (T2DM) along with it so much so that the term diabesity had to be coined. Earlier we had reviewed how to treat the both together and the role of em-pagliflozin to improve cardiovascular outcome trials (CVOT). Similarly T2DM and hypertension are pathophysiologically-related diseases which co-exist with a broader complex of metabolic diseases which co-exist possessing similar set of risk factors. Hence it is important to consider which antihypertensives are suitable that possess a positive effect on metabolic factors in cases of T2DM who require an antihypertensive.
Method: A systematic review was carried out using the PubMed search engine with the MeSH terms: "T2DM"; "essential hyper-tension; "cardiovascular (CV)"; "Complications of diabetes mellitus (DM) and antihypertensive"; "Antihypertensive preferred in T2DM subjects"; "Renin-angiotensin-aldosterone system inhibitors"; "Angiotensin converting enzyme inhibitors (ACEi)"; "Angio-tensin receptor blockers (ARBs)"; "Dihydropyridine calcium channel blocker"; "β2 blockers"; "Diuretics".
Discussion: Most diabetes mellitus (DM) subjects need a minimum of two antihypertensive drugs, combining a renin-angiotensin-aldosterone system (RAS) inhibitor with a dihydropyridine calcium channel blocker seems to be the most indicated approach. But not all dihydropyridine calcium channel blockers have equivalent effects on metabolic parameters. Hence manidipine that causes positive effect on insulin resistance (IR) seems to be an effective option. We have reviewed how manidipine is superior to amlodip-ine with regards to improving IR, not seen with amlodipine, along with not causing excessive sympathetic nervous system (SNS) activation, pulse pressure and ankle edema or to much lesser extent than amlodipine. Therefore, manidipine needs to be the first addition to RAS inhibitors in case of DM's having hypertension of the dihydropyridines calcium channel blockers. Further good blood pressure (BP) control been correlated with good CVs outcomes.
Conclusion: A RAS inhibitor is the first line of choice of drugs in a subject with T2DM who needs to be treated with empagliflozin for better CVOT outcome, and when a 2 nd drug has to be added it is manidipine that is preferred over amlodipine. Plant products are proving to be having a lot of beneficial effects in DM, obesity and hypertension. Thus need for developing agents from plants will prove to be more cost effective in these chronic diseases where compliance is difficult to achieve with the use of common antiDM drugs and antihypertensives with the cost factor along with their side effects.

Muscle relaxant activities of six compounds isolated from Malaysian medicinal plants were investigated on the smooth muscles of the rat aorta and longitudinal muscle of the guinea-pig ileum. Except for goniothalamin, the other five compounds exhibited varying degrees of muscle relaxant activities on the two smooth muscles. Dicentrine, isocorydine, altholactone and usnic acid reduced the contractions to KCI and phenylephrine in the rat aorta, whilst atranorin slightly reduced the contractions to phenylephrine but not KCI. In addition, dicentrine and isocorydine markedly reduced the contractile response to phenylephrine in Ca2+-free Krebs solution. In the longitudinal muscle of the guinea-pig ileum, altholactone, atranorin, dicentrine and isocorydine inhibited to a greater extent the phasic than the tonic responses to KCI. All four compounds similarly inhibited the contractions induced by ACh. The results suggest that the relaxant activities of the compounds are attributed mainly to inhibition of Ca2+ influx via the calcium channels in the membrane of the smooth muscles. Furthermore, the greater sensitivity of dicentrine, isocorydine and altholactone against phenylephrine-induced contractions or KCI-induced phasic contractions are due to their abilities to inhibit intracellular Ca2+ release in these muscles.